stata 14 2 network package (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
stata 14 2 network package
Stata 14 2 Network Package, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 49282 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+14+2+network+package/STATA+14%2E0/pmc11993553-61-9-9
Average 99 stars, based on 49282 article reviews
Stata 14 2 Network Package, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 49282 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+14+2+network+package/STATA+14%2E0/pmc11993553-61-9-9
Average 99 stars, based on 49282 article reviews
stata 14 2 network package - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
other:Article Title: Efficacy and safety of antiplatelet therapy for secondary prevention of small subcortical infarction: A systematic review and network meta-analysis Article Snippet: 14 , 15 Network meta-analysis was performed using the Article Title: Efficacy and safety of antiplatelet therapy for secondary prevention of small subcortical infarction: A systematic review and network meta-analysis Article Snippet: Network meta-analysis was performed using the Software:Article Title: Efficacy and safety of antiplatelet therapy for secondary prevention of small subcortical infarction: A systematic review and network meta-analysis. Article Snippet: Purpose: Small subcortical infarction (SSI) accounts for approximately 25% of ischemic strokes and shares a comparable recurrence rate of cardiovascular events with other stroke subtypes.. This study aimed to evaluate the efficacy and safety of various antiplatelet for secondary prevention of SSI by network meta-analysis (NMA).. Methods: We systematically searched Medline, Embase, Cochrane Library, and Web of Science from inception to October 2024 for randomized controlled trials (RCTs). |